MedTrace Logo

Restylane Shaype Versus Juvederm Volux for Chin Augmentation

NCT06336772 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2025-02-04

No results posted yet for this study

Summary

This study aims to compare two injectable products (Restylane Shaype and Juvéderm Volux) for aesthetic augmentation of the chin

Conditions

  • Chin Retrusion

Interventions

DEVICE

Restylane Shaype

Half (50%) of study participants will receive Restylane Shaype for the treatment of mild to severe chin retrusion

DEVICE

Juvéderm Volux

Half (50%) of study participants will receive Juvéderm Volux for the treatment of mild to severe chin retrusion

Sponsors & Collaborators

  • Erevna Innovations Inc.

    lead OTHER

Principal Investigators

  • Andreas Nikolis, MD · Erevna Innovations Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-10-23
Primary Completion
2024-10-09
Completion
2024-11-09

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06336772 on ClinicalTrials.gov